High concentration of calcium represses osteoblast differentiation in C2C12 cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Calcium is the most abundant stored mineral in the human body and is especially vital for bone health; thus, calcium deficiency can cause bone-related diseases, such as osteopenia and osteoporosis. However, a high concentration of serum calcium, which is commonly known as hypercalcemia, can also lead to weakened bones and, in severe cases, osteosarcoma. Therefore, it is necessary to maintain the concentration of calcium that is appropriate for bone biology. In the present study, we aimed to elucidate the effects of high concentration of calcium, approximately 2 folds the normal calcium level, on osteoblast differentiation. The CaCl2 treatment showed dose-dependent suppression of the alkaline phosphatase activity and mineralized nodule formation. Calcium showed cytotoxicity at an extremely high concentration, but a moderately high concentration of calcium that results in inhibitory effects to osteoblast differentiation showed no signs of cytotoxicity. We also confirmed that the CaCl2 treatment repressed the mRNA expression and protein abundance of various osteogenic genes and transcriptional factors. Considered together, these results indicate that a high concentration of calcium negatively regulates the osteoblast differentiation of C2C12 cells.
Abstract
Calcium is the most abundant stored mineral in the human body and is especially vital for bone health; thus, calcium deficiency can cause bone-related diseases, such as osteopenia and osteoporosis. However, a high concentration of serum calcium, which is commonly known as hypercalcemia, can also lead to weakened bones and, in severe cases, osteosarcoma. Therefore, it is necessary to maintain the concentration of calcium that is appropriate for bone biology. In the present study, we aimed to elucidate the effects of high concentration of calcium, approximately 2 folds the normal calcium level, on osteoblast differentiation. The CaCl2 treatment showed dose-dependent suppression of the alkaline phosphatase activity and mineralized nodule formation. Calcium showed cytotoxicity at an extremely high concentration, but a moderately high concentration of calcium that results in inhibitory effects to osteoblast differentiation showed no signs of cytotoxicity. We also confirmed that the CaCl2 treatment repressed the mRNA expression and protein abundance of various osteogenic genes and transcriptional factors. Considered together, these results indicate that a high concentration of calcium negatively regulates the osteoblast differentiation of C2C12 cells.
참고문헌 (24)
- D. Burkard, "Effects of bone remodeling agents following teriparatide treatment", Osteoporosis International, 29(6), pp.1351~1357 (2018), Springer Science and Business Media LLC[DOI]
- David W Dempster, "Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study", Journal of Bone and Mineral Research, 33(2), pp.298~306 (2018), Wiley[DOI]
- Brendan F Boyce, "Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts", Journal of Bone and Mineral Research, 28(4), pp.711~722 (2013), Wiley[DOI]
- Sengen Sun, "Bone disease drug discovery: examining the interactions between osteoblast and osteoclast", Expert Opinion on Therapeutic Targets, 12(2), pp.239~251 (2008), Informa Healthcare[DOI]
- R. M. Francis, "What do we currently know about nutrition and bone health in relation to United Kingdom public health policy with particular reference to calcium and vitamin D?", British Journal of Nutrition, 99(1), pp.155~159 (2008), Cambridge University Press (CUP)[DOI]
- Khammissa RAG, "The biological activities of vitamin D and its receptor in relation to calcium and bone homeostasis, cancer, immune and cardiovascular systems, skin biology, and oral health", Biomed Res Int, 2018, pp.9276380~ (2018)[DOI]
- Laurence Duplomb, "Concise Review: Embryonic Stem Cells: A New Tool to Study Osteoblast and Osteoclast Differentiation", STEM CELLS, 25(3), pp.544~552 (2007), Wiley[DOI]
- P. Chatakun, "The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature", Cellular and Molecular Life Sciences, 71(1), pp.113~142 (2014), Springer Science and Business Media LLC[DOI]
- Courtney M. Yuen, "Control of Transcription Factor Activity and Osteoblast Differentiation in Mammalian Cells Using an Evolved Small-Molecule-Dependent Intein", Journal of the American Chemical Society, 128(27), pp.8939~8946 (2006), American Chemical Society (ACS)[DOI]
- Kathrin Thor, "Calcium—Nutrient and Messenger", Frontiers in Plant Science, 10, pp.440~ (2019), Frontiers Media SA[DOI]
- Nigel Crawford, "Nutrient Signaling by Nitrate and Calcium", Plant Physiology, 169(2), pp.911~911 (2015), Oxford University Press (OUP)[DOI]
- Einhorn TA, "Nutrition and bone", Orthop Clin North Am, 21, pp.43~50 (1990)
- W R McKane, "Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study.", The Journal of Clinical Endocrinology & Metabolism, 80(12), pp.3458~3464 (1995), The Endocrine Society[DOI]
- Virginia L. Ernster, "Benefits and risks of menopausal estrogen and", or progestin hormone use, 1988, pp.17(2), 201~223[DOI]
- Kristin K. Clemens, "Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study", Archives of Osteoporosis, 15(1), pp.133~ (2020), Springer Science and Business Media LLC[DOI]
- M. Annefeld, "The influence of ossein-hydroxyapatite compound (‘Ossopan’) on the healing of a bone defect", Current Medical Research and Opinion, 10(4), pp.241~250 (2008), Informa Healthcare[DOI]
- Tetsuyuki Kiyokawa, "Hypercalcemia and osteoclast proliferation in adult T-cell leukemia", Cancer, 59(6), pp.1187~1191 (1987), Wiley[DOI]
- Abrea Roark, "Hypercalcemia: an unusual etiology of a common menopausal symptom", Fertility and Sterility, 95(7), pp.2434.e7~2434.e9 (2011), Elsevier BV[DOI]
- Arkady Rutkovskiy, "Osteoblast Differentiation at a Glance", Medical Science Monitor Basic Research, 22, pp.95~106 (2016), International Scientific Information, Inc.[DOI]
- Toshihisa Komori, "Runx2, A multifunctional transcription factor in skeletal development", Journal of Cellular Biochemistry, 87(1), pp.1~8 (2002), Wiley[DOI]
- Komori T, "Requisite roles of Runx2 and Cbfb in skeletal development", J Bone Miner Metab, 21, pp.193~197 (2003)[DOI]
- Komori T, "Functions of BMPs, Runx2, and osterix in the development of bone and cartilage", Nihon Rinsho, 63, pp.1671~1677 (2005)
- You Hee Choi, "Cbl-b and c-Cbl negatively regulate osteoblast differentiation by enhancing ubiquitination and degradation of Osterix", Bone, 75, pp.201~209 (2015), Elsevier BV[DOI]
- Wei Zhu, "The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation", Journal of Biological Chemistry, 292(27), pp.11178~11188 (2017), Elsevier BV[DOI]
